Brief: Evaxion Significantly Expands Vaccine Development Collaboration With MSD

Evaxion A/S

26/09/2024 12:45

Sept 26 (Reuters) - Evaxion Biotech A/S  EVAX.O :
    * EVAXION SIGNIFICANTLY EXPANDS VACCINE DEVELOPMENT
COLLABORATION
WITH MSD
    * EVAXION BIOTECH A/S - ENTERS OPTION AND LICENSE AGREEMENT
WITH
MSD
    * EVAXION BIOTECH A/S - MSD GRANTED OPTION TO LICENSE
EVAXION'S
EVX-B2 AND EVX-B3
    * EVAXION BIOTECH A/S - TO RECEIVE $3.2 MILLION UPFRONT, UP
TO $10
MILLION IN 2025
    * EVAXION BIOTECH A/S - ELIGIBLE FOR UP TO $592 MILLION PER
PRODUCT IN MILESTONES

Source text for Eikon:  ID:nGNX705f27 
Further company coverage:  EVAX.O 

 ((Reuters.Briefs@thomsonreuters.com;))